Publication | Closed Access

Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

ThrombosisPlasma FibrinogenCardiovascular DiseaseFibrinolytic SystemHematologyFibrinolysisCoagulopathyNeurologyAcute Myocardial InfarctionMedicineAnticoagulantCardiologyAnesthesiologyMyocardial Infarction